Key Points A notable bank and a major investment management firm bought more shares of Johnson & Johnson. The healthcare giant has performed well this year despite some significant headwinds. The drugmaker is well equipped to deal with these challenges over the long term. 10 stocks we like better than Johnson & Johnson › Pharmaceutical giant Johnson & Johnson (NYSE: JNJ) has performed well this year. The company's shares are up by 45% since January. However, many investors, including institutio ...